Postoperative management of trabeculectomy and glaucoma drainage implant surgery
暂无分享,去创建一个
[1] J. Caprioli,et al. Early Aqueous Suppressant Therapy on Hypertensive Phase Following Glaucoma Drainage Device Procedure: A Randomized Prospective Trial , 2016, Journal of glaucoma.
[2] Dan Lindfield,et al. The “Pull-Through” Suture; Facilitating Watertight Anterior Chamber Entry and Minimizing Early Hypotony in Glaucoma Tube Surgery , 2016, Journal of glaucoma.
[3] P. Artes,et al. Systematic Occlusion of Shunts: Control of Early Postoperative IOP and Hypotony-related Complications Following Glaucoma Shunt Surgery , 2016, Journal of glaucoma.
[4] M. Lynn,et al. Glaucoma drainage devices: risk of exposure and infection. , 2015, American journal of ophthalmology.
[5] J. Tsai,et al. Current concepts in the treatment of vitreous block, also known as aqueous misdirection. , 2015, Survey of ophthalmology.
[6] W. Feuer,et al. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. , 2014, Ophthalmology.
[7] V. Cvintal,et al. Tube shunt coverage with gamma-irradiated cornea allograft (VisionGraft) , 2015, Clinical ophthalmology.
[8] C. Curcio,et al. Outcomes of Shunt Tube Coverage With Glycerol Preserved Cornea Versus Pericardium , 2014, Journal of glaucoma.
[9] Xiulan Zhang,et al. Trabeculectomy with versus without releasable sutures for glaucoma: a meta-analysis of randomized controlled trials , 2014, BMC Ophthalmology.
[10] Zhiliang Li,et al. Anti-VEGF Agents with or without Antimetabolites in Trabeculectomy for Glaucoma: A Meta-Analysis , 2014, PloS one.
[11] M. Sherwood,et al. Randomized, prospective, comparative trial of EX-PRESS glaucoma filtration device versus trabeculectomy (XVT study). , 2014, American journal of ophthalmology.
[12] I. Scott,et al. Mitomycin C versus 5‐fluorouracil as an adjunctive treatment for trabeculectomy: a meta‐analysis of randomized clinical trials , 2013, Clinical & experimental ophthalmology.
[13] D. Grover,et al. Forniceal conjunctival pedicle flap for the treatment of complex glaucoma drainage device tube erosion. , 2013, JAMA ophthalmology.
[14] D. Zurakowski,et al. The Ahmed versus Baerveldt study: three-year treatment outcomes. , 2013, Ophthalmology.
[15] W. Feuer,et al. Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up. , 2012, American journal of ophthalmology.
[16] J. Salmon,et al. Malignant Glaucoma: A Review of the Modern Literature , 2012, Journal of ophthalmology.
[17] Eun Suk Lee,et al. Split-thickness hinged scleral flap in the management of exposed tubing of a glaucoma drainage device. , 2011, Journal of glaucoma.
[18] W. Feuer,et al. Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up. , 2011, Ophthalmology.
[19] W. Spileers,et al. Outcomes of different management options for malignant glaucoma: a retrospective study , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.
[20] P. McCluskey,et al. Graft-free Molteno tube insertion: 10-year outcomes , 2010, British Journal of Ophthalmology.
[21] W. C. Stewart,et al. Incidence of Conjunctival Exposure following Drainage Device Implantation in Patients with Glaucoma , 2010, European journal of ophthalmology.
[22] G. Spaeth,et al. The Early Flat Anterior Chamber After Trabeculectomy: A Randomized, Prospective Study of 3 Methods of Management , 2009, Journal of glaucoma.
[23] D. Grewal,et al. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study. , 2008, Ophthalmology.
[24] J. Jonas,et al. Intravitreal Bevacizumab for Filtering Surgery , 2007, Ophthalmic Research.
[25] H. Jampel,et al. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). , 2005, American journal of ophthalmology.
[26] P. Airaksinen,et al. Placing the Molteno implant in a long scleral tunnel to prevent postoperative tube exposure. , 2005, Acta ophthalmologica Scandinavica.
[27] J. Caprioli,et al. Evaluation of the hypertensive phase after insertion of the Ahmed Glaucoma Valve. , 2003, American journal of ophthalmology.
[28] Alyson K. Zalta,et al. Intracameral tissue plasminogen activator use in a large series of eyes with valved glaucoma drainage implants. , 2002, Archives of ophthalmology.
[29] A. Investigators. The Advanced Glaucoma Intervention Study (AGIS): 11. Risk factors for failure of trabeculectomy and argon laser trabeculoplasty. , 2002, American journal of ophthalmology.
[30] W. Feuer,et al. Prognosis and risk factors for early postoperative wound leaks after trabeculectomy with and without 5-fluorouracil. , 2001, American journal of ophthalmology.
[31] H. Flynn,et al. Late endophthalmitis associated with glaucoma drainage implants. , 2001, Ophthalmology.
[32] G. Spaeth,et al. Evaluation of Nd:YAG laser membranectomy in blocked tubes after glaucoma tube-shunt surgery. , 1997, American journal of ophthalmology.
[33] L. Labree,et al. Laser suture lysis after mitomycin C trabeculectomy. , 1996, Ophthalmology.
[34] Paul A. Sidoti,et al. Tissue Plasminogen Activator and Glaucoma Drainage Implants , 1995, Journal of glaucoma.
[35] A. Zaczek. [5-Fluorouracil in glaucoma surgery]. , 1994, Klinika oczna.
[36] D. Minckler,et al. Echographic evaluation of glaucoma shunts. , 1993, Ophthalmology.
[37] M. Lieberman,et al. Drainage implant surgery for refractory glaucoma. , 1990, International ophthalmology clinics.
[38] Roper v. Simmons,et al. Malignant glaucoma. , 1972, The British journal of ophthalmology.